The CD28 family molecules, CD28, and inducible costimulator (ICOS) all provide positive costimulatory signals. However, unlike CD28, ICOS does not costimulate IL-2 secretion. The YMNM motif that exists in the CD28 cytoplasmic domain is a known binding site for phosphatidylinositol 3-kinase (PI3-K) and Grb2. ICOS possesses the YMFM motif in the corresponding region of CD28 that binds PI3-K but not Grb2. We postulated that the reason that ICOS does not have the ability to induce IL-2 production is because it fails to recruit Grb2. To verify this hypothesis, we generated a mutant ICOS gene that contains the CD28 YMNM motif and measured IL-2 promoter activation after ICOS ligation. The results indicated that ICOS became competent to activate the IL-2 promoter by this single alteration. Further analysis demonstrated that Grb2 binding to ICOS was sufficient to activate the NFAT/AP-1 site in the IL-2 promoter and that the cytoplasmic domain of CD28 outside of the YMNM motif is required for activation of the CD28RE/AP-1 and NF-κB sites. Together, these observations lead us to believe that the difference of a single amino acid, which affects Grb2 binding ability, may define a functional difference between the CD28- and ICOS-mediated costimulatory signals.
Skip Nav Destination
Article navigation
20 January 2003
Article Contents
Brief Definitive Report|
January 20 2003
A Single Amino Acid Alteration in Cytoplasmic Domain Determines IL-2 Promoter Activation by Ligation of CD28 but Not Inducible Costimulator (ICOS)
Yohsuke Harada,
Yohsuke Harada
1Research Institute for Biological Sciences, Faculty of Science and Technology, Tokyo University of Science, Chiba 278-0022, Japan
Search for other works by this author on:
Daisuke Ohgai,
Daisuke Ohgai
1Research Institute for Biological Sciences, Faculty of Science and Technology, Tokyo University of Science, Chiba 278-0022, Japan
Search for other works by this author on:
Ryosuke Watanabe,
Ryosuke Watanabe
1Research Institute for Biological Sciences, Faculty of Science and Technology, Tokyo University of Science, Chiba 278-0022, Japan
Search for other works by this author on:
Kazuhiro Okano,
Kazuhiro Okano
1Research Institute for Biological Sciences, Faculty of Science and Technology, Tokyo University of Science, Chiba 278-0022, Japan
Search for other works by this author on:
Osamu Koiwai,
Osamu Koiwai
3Department of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, Chiba 278-0022, Japan
Search for other works by this author on:
Kazunari Tanabe,
Kazunari Tanabe
4Department of Urology, Tokyo Women's Medical University, Tokyo 162-8666, Japan
Search for other works by this author on:
Hiroshi Toma,
Hiroshi Toma
4Department of Urology, Tokyo Women's Medical University, Tokyo 162-8666, Japan
Search for other works by this author on:
Amnon Altman,
Amnon Altman
5Division of Cell Biology, La Jolla Institute for Allergy and Immunology, San Diego, CA 92121
Search for other works by this author on:
Ryo Abe
Ryo Abe
1Research Institute for Biological Sciences, Faculty of Science and Technology, Tokyo University of Science, Chiba 278-0022, Japan
2Genome and Drug Research Center, Faculty of Science and Technology, Tokyo University of Science, Chiba 278-0022, Japan
Search for other works by this author on:
Yohsuke Harada
1Research Institute for Biological Sciences, Faculty of Science and Technology, Tokyo University of Science, Chiba 278-0022, Japan
Daisuke Ohgai
1Research Institute for Biological Sciences, Faculty of Science and Technology, Tokyo University of Science, Chiba 278-0022, Japan
Ryosuke Watanabe
1Research Institute for Biological Sciences, Faculty of Science and Technology, Tokyo University of Science, Chiba 278-0022, Japan
Kazuhiro Okano
1Research Institute for Biological Sciences, Faculty of Science and Technology, Tokyo University of Science, Chiba 278-0022, Japan
Osamu Koiwai
3Department of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, Chiba 278-0022, Japan
Kazunari Tanabe
4Department of Urology, Tokyo Women's Medical University, Tokyo 162-8666, Japan
Hiroshi Toma
4Department of Urology, Tokyo Women's Medical University, Tokyo 162-8666, Japan
Amnon Altman
5Division of Cell Biology, La Jolla Institute for Allergy and Immunology, San Diego, CA 92121
Ryo Abe
1Research Institute for Biological Sciences, Faculty of Science and Technology, Tokyo University of Science, Chiba 278-0022, Japan
2Genome and Drug Research Center, Faculty of Science and Technology, Tokyo University of Science, Chiba 278-0022, Japan
Address correspondence to Dr. Ryo Abe, Research Institute for Biological Sciences, Tokyo University of Science, 2669 Yamazaki, Noda, Chiba 278-0022, Japan. Phone: 81-4-7123-9756; Fax: 81-4-7124-1955; E-mail: [email protected]
Received:
July 31 2002
Revision Received:
November 08 2002
Accepted:
December 03 2002
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2003
J Exp Med (2003) 197 (2): 257–262.
Article history
Received:
July 31 2002
Revision Received:
November 08 2002
Accepted:
December 03 2002
Citation
Yohsuke Harada, Daisuke Ohgai, Ryosuke Watanabe, Kazuhiro Okano, Osamu Koiwai, Kazunari Tanabe, Hiroshi Toma, Amnon Altman, Ryo Abe; A Single Amino Acid Alteration in Cytoplasmic Domain Determines IL-2 Promoter Activation by Ligation of CD28 but Not Inducible Costimulator (ICOS) . J Exp Med 20 January 2003; 197 (2): 257–262. doi: https://doi.org/10.1084/jem.20021305
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement